Search

everythinglearnresearchcommunity

for

Search:↓

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

NAFLD in PCOS patients is linked to early kidney problems.

TGF-alpha affects skin thickness, hair growth, and may contribute to psoriasis and papilloma formation.

YAP and TAZ are crucial for skin cell growth and repair.

Blocking EGFR in mice causes hair loss and skin changes.

EGFR signaling is crucial for skin and hair health, and targeting it could help treat skin diseases and cancer.

Blocking Hedgehog signaling offers new treatment options for advanced basal cell carcinoma.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

Iressa often causes skin issues like acne and dryness in lung cancer patients.

EGFR is essential for normal hair development and follicle differentiation.

Understanding EGFR's role in skin is crucial for better treatments and managing side effects.

EGF controls hair growth by regulating hair follicles' growth phases.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Epidermal growth factor helps hair stem cells grow by activating specific cell pathways.

Keratin 16 delays skin maturation and affects skin and hair development in mice.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Inactivating both p53 and Rb genes in mice speeds up aggressive skin cancer development.

Gefitinib can cause hair loss without scarring.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

EGFR inhibitors can cause skin issues like acne and dryness, but these can be managed without stopping treatment.

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

Understanding EGFR roles could lead to new hair loss treatments.

A cancer patient died from a severe skin reaction after taking the drug cetuximab.

Overexpressing the epigen gene in mice leads to enlarged sebaceous glands and greasy fur.

Erlotinib can cause nonscarring hair loss and itchy skin.

Erlotinib may cause scarring hair loss.

Reduced EGFR signaling delays hair cycle and reduces fat growth, but hair development remains normal.

Cetuximab can cause eyelash growth, which is rare but manageable.